Fine. Couldn’t really find anything to buy but had eye on Pfizer for few months so I bought 50 shares for 38.50 USD per share. Previous exit wasn’t exactly a good move if possible problems with spin off taxation are excluded. Solid company and solid operating environment with the ever ongoing COVID-19 situation, increased vaccine production capacity and all the other product lines. I’ll probably add on this gradually and also look into entering Abbvie position as well since this is a sector I’d like to increase my exposure in.